ENTITY
Mabpharm

Mabpharm (2181 HK)

23
Analysis
Industrials • Hong Kong
Mabpharm is a biopharmaceutical company specializing in the research, development, and manufacturing of monoclonal antibody drugs and biosimilars for cancer and autoimmune diseases. Its core products include CMAB009 Enlito, CMAB007 AomaiShu, and CMAB008 Leiting, which treat various conditions such as colorectal cancer, asthma, and rheumatoid arthritis. The company was founded in 2009 and is headquartered in Taizhou, Jiangsu, PRC.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x